Babylon Responds to Speculations
AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”), one of…
Year: 2022
Fortune Minerals Negotiates Agreement in Principle to Extend the Term of Its 2015 Debentures
New United States Inflation Reduction Act includes measures to positively impact North American critical minerals…
3CLogic Announces Integration for ServiceNow Healthcare and Life Sciences Service Management Product
Leading provider of cloud call center solutions expands existing ServiceNow offering to extend powerful live…
Volkswagen Supply Win Will Send Innoviz To The Top According To Strategy Analytics LiDAR Market Share Estimates
Supply Win Due To Single Laser Design And Understanding Production Processes BOSTON–(BUSINESS WIRE)–On August 2nd,…
Hoptroff appoint Chief Revenue Officer to underpin strategic vision for the company
New York, 16th of August 2022: Hoptroff, the timing solutions provider offering resilient, traceable, and…
Sunlight Care Group adopts CareLineLive’s home care management software
London-based care agency adopts all-in-one home care management software to connect managers, carers and clients…
Westcon-Comstor EMEA is Extreme Networks’ 2022 International Distributor of the Year
Renowned award honours the specialist distributor’s commitment and performance in bringing Extreme Networks solutions to…
Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates
– ColoAlert to be marketed through Dante’s extensive database and sold via its region-specific, ecommerce…
Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates
ColoAlert to be marketed through Dante’s extensive database and sold via its region-specific, ecommerce websites…
Saniona progresses its Kv7 epilepsy program into Lead Optimization
PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced…
OKYO Pharma Limited – Final audited results for the year ended 31 March 2022
LONDON and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO;…
Basilea reports strong financial half-year results and progress in the implementation of new anti-infectives strategy
CHF 29 million royalty income (+22.5% year-on-year) reflecting continued commercial success of Cresemba Continued improvement…
Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, France Latest expansions represent…
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
First new treatment regimen in more than 20 years to significantly improve outcomes in people…
Towards Next-Generation Digital Therapeutics – BELL Therapeutics Announces New Partnership with Prof. Jung, Seoul National University Hospital
BELL’s new partnership will shed light on further potentials for digital therapeutics by overcoming limitations…
Eloboss Introduces Gaming Solution by Connecting Players with Experts to Improve League Rating
Eloboss, a gaming solution provides a wide range of services to help players improve CS:GO…
Bintai Kinden Appointed by South Korean Company to Market Piping and Fitting Products
PETALING JAYA, Malaysia, Aug 16, 2022 – (ACN Newswire) – Mechanical and electrical (M&E) engineering…
Axo Announces Acquisition of Defero, a Leading Digital Credit-Scoring and Financial Management Platform
Addition of Defero’s Consumer-Focused Credit Scoring Platform Further Differentiates Axo as the Broker-of-Choice in the…
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
Zarrinpar Laboratory finds that engineering of native bacteria for therapeutic applications facilitates long term engraftment…
TELA Bio Announces Pricing of Public Offering of Common Stock
MALVERN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…